Vikram Pattanayak, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endonucleases | 4 | 2016 | 371 | 0.930 |
Why?
|
| HLA Antigens | 3 | 2023 | 1334 | 0.710 |
Why?
|
| Genetic Engineering | 3 | 2016 | 936 | 0.670 |
Why?
|
| Zinc Fingers | 2 | 2013 | 577 | 0.410 |
Why?
|
| Substrate Specificity | 4 | 2016 | 1751 | 0.400 |
Why?
|
| Oligonucleotide Probes | 2 | 2008 | 417 | 0.350 |
Why?
|
| Endodeoxyribonucleases | 1 | 2011 | 165 | 0.350 |
Why?
|
| Nucleic Acid Conformation | 2 | 2008 | 899 | 0.280 |
Why?
|
| DNA | 6 | 2016 | 7214 | 0.270 |
Why?
|
| Kidney Transplantation | 4 | 2023 | 4262 | 0.270 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 4786 | 0.230 |
Why?
|
| DNA Cleavage | 2 | 2014 | 56 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 3671 | 0.200 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 1930 | 0.200 |
Why?
|
| Deoxyribonucleases | 2 | 2014 | 209 | 0.200 |
Why?
|
| Genome | 3 | 2015 | 1754 | 0.190 |
Why?
|
| Codes of Ethics | 1 | 2021 | 61 | 0.180 |
Why?
|
| Genome, Insect | 1 | 2021 | 96 | 0.180 |
Why?
|
| Base Sequence | 7 | 2016 | 12421 | 0.180 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2020 | 37 | 0.170 |
Why?
|
| Anaplasmosis | 1 | 2020 | 37 | 0.170 |
Why?
|
| Anopheles | 1 | 2021 | 193 | 0.160 |
Why?
|
| Platelet Transfusion | 1 | 2021 | 301 | 0.150 |
Why?
|
| RNA, Messenger | 3 | 2008 | 12800 | 0.150 |
Why?
|
| Epitopes | 1 | 2022 | 2528 | 0.130 |
Why?
|
| Histocompatibility Testing | 3 | 2023 | 716 | 0.120 |
Why?
|
| Keratinocytes | 1 | 2019 | 876 | 0.120 |
Why?
|
| Streptococcus pyogenes | 2 | 2016 | 293 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 1798 | 0.110 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2019 | 565 | 0.110 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 77 | 0.100 |
Why?
|
| Malaria | 1 | 2021 | 1249 | 0.090 |
Why?
|
| Blood Platelets | 1 | 2021 | 2479 | 0.090 |
Why?
|
| Protein Engineering | 1 | 2014 | 553 | 0.090 |
Why?
|
| K562 Cells | 1 | 2011 | 644 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2022 | 4492 | 0.080 |
Why?
|
| Isoantibodies | 2 | 2023 | 681 | 0.080 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2008 | 111 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4283 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2008 | 725 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2005 | 1305 | 0.070 |
Why?
|
| Binding Sites | 2 | 2014 | 6020 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2008 | 591 | 0.070 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2006 | 167 | 0.060 |
Why?
|
| RNA, Antisense | 1 | 2005 | 136 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 57 | 0.060 |
Why?
|
| Models, Molecular | 3 | 2015 | 5403 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5706 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 4058 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 3840 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5863 | 0.050 |
Why?
|
| Genome, Human | 1 | 2016 | 4446 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13421 | 0.050 |
Why?
|
| Humans | 18 | 2023 | 768166 | 0.050 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2022 | 126 | 0.050 |
Why?
|
| Introduced Species | 1 | 2021 | 10 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2015 | 19015 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17622 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3216 | 0.040 |
Why?
|
| Vaccination | 2 | 2023 | 3437 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 9615 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 622 | 0.040 |
Why?
|
| Blood Donors | 1 | 2021 | 343 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2020 | 406 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2013 | 6283 | 0.040 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 219 | 0.040 |
Why?
|
| Morals | 1 | 2021 | 288 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2022 | 1393 | 0.040 |
Why?
|
| Genomics | 1 | 2013 | 5926 | 0.040 |
Why?
|
| Ecosystem | 1 | 2021 | 494 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3428 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2022 | 1561 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2005 | 82 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2421 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2022 | 4833 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2023 | 2381 | 0.030 |
Why?
|
| Protein Binding | 2 | 2016 | 9343 | 0.030 |
Why?
|
| Animals | 5 | 2021 | 169246 | 0.020 |
Why?
|
| Cricetinae | 2 | 2005 | 2423 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2013 | 491 | 0.020 |
Why?
|
| Patient Selection | 1 | 2023 | 4260 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2014 | 841 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2015 | 966 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 742 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 4249 | 0.020 |
Why?
|
| Ligands | 1 | 2015 | 3284 | 0.020 |
Why?
|
| Public Health | 1 | 2021 | 2679 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9613 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 3956 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54926 | 0.020 |
Why?
|
| Cell Line | 2 | 2014 | 15597 | 0.020 |
Why?
|
| RNA | 1 | 2016 | 2720 | 0.020 |
Why?
|
| Mutation | 3 | 2018 | 30238 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2005 | 190 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3514 | 0.010 |
Why?
|
| Plasmids | 1 | 2006 | 2269 | 0.010 |
Why?
|
| Male | 3 | 2023 | 364719 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 2665 | 0.010 |
Why?
|
| Rabbits | 1 | 2005 | 4772 | 0.010 |
Why?
|
| Female | 3 | 2023 | 397192 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18065 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 2094 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20227 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1896 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41754 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 1839 | 0.010 |
Why?
|
| Middle Aged | 2 | 2022 | 223492 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4528 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7608 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 81762 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 171504 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12168 | 0.000 |
Why?
|